MAPT and Alzheimer disease: Alzheimer’s disease (AD) is a slowly developing neurodegenerative disorder characterized by the accumulation of beta-amyloid plaques (Aβ) and tau neurofibrillary tangles (NFTs) in the brain, often decades before a patient becomes symptomatic.